# Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

> **NCT03199794** · — · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 50 (actual)

## Conditions studied

- Acquired Hemophilia A

## Interventions

- **BIOLOGICAL:** OBIZUR

## Key facts

- **NCT ID:** NCT03199794
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-14
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199794, "Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03199794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*